Teva Pharmaceutical (TEVA) Buy, Sell or Hold

Teva Pharmaceutical (TEVA)

39.65

+0.12 (0.30%)

as of Oct 5, 2026, 7:59:59 pm Market Open.

71 watching

TOP PICK

Generic drugs. Manufactures more than 25% of the US market. In a move to more universal medicine in the US, generic manufacturers are going to be big beneficiaries. Earnings are likely to increase by 50% in the 2009 to 2012 period. Trading at 15X earnings.

COMMENT

(Market Call Minute.) Likes this as a company. In the very short run the health care stocks are under performing in the last couple of weeks. If you like pharmaceuticals, this is one that you could purchase.

DON'T BUY

Outsource pharmaceutical manufacturer of generic drugs. No barriers to stop others from doing the same kind of business. He prefers Johnson & Johnson (JNJ-N) or Novartis (NVS-N) who specialize in what they do.

BUY

Trading down 5% on a one-year basis and 14 X forward earnings. This would be a more conservative buy then Gilead (GILD-Q).

TOP PICK

World's leading generic drug manufacturer. Buying Barr Laboratories, which will broaden its product range and increase its strength. Generic drugs are a solution to a lot of the problems that are facing the global health industry.

TOP PICK

Largest generic drug company in the world. Company outlook was better than what the Street was looking for. People are moving more towards generics as economies weaken. (Recommends you do partial buys on a gradual basis.)

PAST TOP PICK

(Top Pick Oct 23/07, Down 4%). World’s largest generic drug manufacturer; owns some brand name drugs, picks up drugs when they go off patent. Combine with owning a brand name drug company in portfolio. It’s a buy today. 3-5 years down the road, growth is in drugs coming off patent.

TOP PICK

Biggest Generic Drug manufacturer, getting into Japan where only a small percentage is generic. Strong cash flow.

PAST TOP PICK

(A Top Pick Sept 11/07. Up 12%.) Generics are the best place to be in pharmaceuticals. This is the largest, the leader and the fastest growing. Has the best products coming on. Have made some great acquisitions.

COMMENT

An interesting stock as this is one of the best generic drug manufacturers. Increasingly, as the blockbuster drugs do come off patent, there is probably more upside with the generics. Not a fan of pharmaceuticals because of the potential for litigation.

COMMENT

Global pharmaceutical. In a trading range for almost a year. Not a particularly high R & D industry. A lot of generics. It might add a lot of stability to a portfolio. Prefers Johnson & Johnson (JNJ-N).

TOP PICK

Leading by far the number of potential drugs that they can manufacture. Very well tied in to the Israeli technology sector. Have the first drug that shows a reduced effect of Parkinson's.

TOP PICK

Largest generic drug manufacturer globally. Acquiring Barr Labs (BRL-N) giving them more international exposure. Also have some proprietary drugs, most importantly a Parkinson drug.

TOP PICK

Largest generic drug company in the world. Have the leading drug for multiple sclerosis that is going to be produced generically by competition but will take 3 or 4 years. Just announced 3rd stage of a drug for Parkinson’s that is the only one that has slowed and possibly stopped the progression of Parkinson's. Has many years of patent protection.

BUY

(Market Call Minute.) Biggest generic drug manufacturer in the world. More and more drugs are coming off patent so the growth outlook is fabulous.

Showing 211 to 225 of 279 entries

Most Recent Experts

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Bruce Murray

The Murray Wealth Group

Dennis Mitchell, CFA

Sentry Select Capital Corp

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Teva Pharmaceutical (TEVA)